Patents by Inventor John Clifford Chabala

John Clifford Chabala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods of treating retinal disease
    Patent number: 11724987
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: August 15, 2023
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20230041335
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: September 1, 2022
    Publication date: February 9, 2023
    Inventors: Thomas A. JORDAN, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20210269402
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Application
    Filed: February 1, 2021
    Publication date: September 2, 2021
    Inventors: Thomas A. JORDAN, John E. DOWLING, John Clifford CHABALA
  • Compositions and methods of treating retinal disease
    Patent number: 10913722
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: February 9, 2021
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20190210971
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: January 7, 2019
    Publication date: July 11, 2019
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION
    Publication number: 20190125729
    Abstract: The present invention is directed to compounds of formula (A): pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.
    Type: Application
    Filed: October 23, 2018
    Publication date: May 2, 2019
    Inventors: John Clifford Chabala, Thomas A. Jordan, Ke-Qing Ling, John G. Gleason, William A. Kinney
  • Compositions and methods of treating retinal disease
    Patent number: 10202348
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: January 3, 2018
    Date of Patent: February 12, 2019
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Traps in the treatment of macular degeneration
    Patent number: 10111862
    Abstract: The present invention is directed to compounds of formula (A): pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.
    Type: Grant
    Filed: January 21, 2014
    Date of Patent: October 30, 2018
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: John Clifford Chabala, Thomas A. Jordan, Ke-Qing Ling, John G. Gleason, William A. Kinney
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20180194733
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: January 3, 2018
    Publication date: July 12, 2018
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION
    Publication number: 20180092882
    Abstract: The present invention is directed to topical ophthalmic compositions of a lipophilic compound and an oligomeric or polymeric carrier wherein the compositions are useful in the treatment and prevention of macular degeneration. The invention also includes methods of treating macular degeneration by using a topical ophthalmic composition of a lipophilic compound and an oligomeric or polymeric carrier.
    Type: Application
    Filed: October 12, 2017
    Publication date: April 5, 2018
    Inventors: Thomas A. Jordan, John Clifford Chabala, Gerald D. Cagle
  • Compositions and methods of treating retinal disease
    Patent number: 9896419
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: February 20, 2018
    Assignee: ALDEYRA THERAPEUTICS, INC.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods for the treatment of macular degeneration
    Patent number: 9814701
    Abstract: The present invention is directed to topical ophthalmic compositions of a lipophilic compound and an oligomeric or polymeric carrier wherein the compositions are useful in the treatment and prevention of macular degeneration. The invention also includes methods of treating macular degeneration by using a topical ophthalmic composition of a lipophilic compound and an oligomeric or polymeric carrier.
    Type: Grant
    Filed: December 9, 2010
    Date of Patent: November 14, 2017
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John Clifford Chabala, Gerald D. Cagle
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20170320829
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: April 14, 2017
    Publication date: November 9, 2017
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9650342
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: May 16, 2017
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Peri-carbinols
    Patent number: 9604997
    Abstract: The present invention is directed to compounds of formula (I): pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: March 28, 2017
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John Clifford Chabala, Ke-Qing Ling, William A. Kinney
  • COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
    Publication number: 20160168098
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed
    Type: Application
    Filed: February 22, 2016
    Publication date: June 16, 2016
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9364471
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: June 14, 2016
    Assignee: ALDEYRA THERAPEUTICS, INC.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • Compositions and methods of treating retinal disease
    Patent number: 9265759
    Abstract: Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: February 23, 2016
    Assignee: Aldeyra Therapeutics, Inc.
    Inventors: Thomas A. Jordan, John E. Dowling, John Clifford Chabala
  • PERI-CARBINOLS
    Publication number: 20150344432
    Abstract: The present invention is directed to compounds of formula(I): pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.
    Type: Application
    Filed: December 19, 2013
    Publication date: December 3, 2015
    Inventors: Thomas A. Jordan, John Clifford Chabala, Ke-Qing Ling, William A. Kinney
  • NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION
    Publication number: 20150344447
    Abstract: The present invention is directed to compounds of formula (A): pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.
    Type: Application
    Filed: January 21, 2014
    Publication date: December 3, 2015
    Inventors: John Clifford Chabala, Thomas A. Jordan, Ke-Qing Ling, John G. Gleason, William A. Kinney